bempegaldesleukin
Generic: Bempegaldesleukin
bempegaldesleukin: 1 clinical trial tracked.
bempegaldesleukin evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about bempegaldesleukin, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase 3, Randomized, Open-label Study of NKTR-214 Combined With Nivolumab Versus Nivolumab in Participants With Previously Untreated Unresectable or Metastatic Melanoma
Primary endpoint: Objective Response Rate (ORR) Per Blinded Independent Central Review (BICR)
InterventionalRandomizedopen783 enrolledStarted 2018-09Completion 2024-0350 sites · Argentina, Australia, Austria, Belgium…Bristol-Myers Squibb